Imithi yokwehlisa isisindo

Kunemithi ehlukahlukene esetshenziselwa ukwehlisa isisindo. Ngaphambi kokuzama imithi yokwehlisa isisindo, umhlinzeki wakho wokunakekelwa kwezempilo uzoncoma ukuthi uzame izindlela ezingezona izidakamizwa zokwehlisa isisindo. Ngenkathi izidakamizwa zokwehlisa isisindo zingasiza, ukwehla kwesisindo okuphelele kufinyelelwe kunqunyelwe kubantu abaningi. Ngaphezu kwalokho, kungenzeka ukuthi isisindo sizophinde sitholakale lapho imithi imiswa.

Imithi eminingi yokwehlisa isisindo iyatholakala. Cishe kungamakhilogremu ama-5 kuye kwayi-10 (2 kuya ku-4.5 kilograms) angalahleka ngokuthatha le mithi. Kepha akuwona wonke umuntu owehlisa isisindo ngenkathi ebathatha. Iningi labantu liphinde libuyise isisindo ngemuva kokuyeka ukuthatha imishanguzo, ngaphandle kokuthi benze ushintsho lwendlela yokuphila engapheli. Lezi zinguquko zifaka ukuzivocavoca umzimba ngaphezulu, ukusika ukudla okungenampilo ekudleni kwabo, nokunciphisa inani abalidlayo.

Ungabona nezikhangiso zemithi engamakhambi nezengezo ezithi zikusize wehlise isisindo. Eziningi zalezi zimangalo azilona iqiniso. Ezinye zalezi zithasiselo zingaba nemiphumela emibi kakhulu.

Inothi labesifazane: Abesifazane abakhulelwe noma abahlengikazi akufanele bathathe imishanguzo yokudla. Lokhu kufaka phakathi amakhambi kadokotela, amakhambi namakhambi. I-Over-the-counter ibhekisela emithini, amakhambi, noma izithako ongazithenga ngaphandle kwemithi kadokotela.

Imithi ehlukene yokwehlisa isisindo ichazwe ngezansi. Qiniseka ukuthi ukhuluma nomhlinzeki wakho mayelana nokuthi imuphi umuthi ofanele wena.

I-ORLISTAT (XENICAL NE-ALLI)

I-Orlistat isebenza ngokwehlisa ukumuncwa kwamafutha emathunjini cishe nge-30%. Kuvunyelwe ukusetshenziswa kwesikhathi eside.

Cishe ngamakhilogremu ama-6 (ama-3 kilograms) noma kuze kufike ku-6% wesisindo somzimba singalahleka uma usebenzisa lo muthi. Kepha hhayi wonke umuntu wehlisa isisindo ngenkathi ethatha. Abantu abaningi baphinde babuyisele isisindo sabo eminyakeni emibili ngemuva kokuyeka ukusisebenzisa.

Umphumela omubi kakhulu we-orlistat uhudo olunamafutha olungaphuma endunu. Ukudla ukudla okunamafutha okumbalwa kunganciphisa lo mphumela. Ngaphandle kwalo mphumela wecala, iningi labantu liyawubekezelela lo muthi.

I-Xenical wuhlobo lwe-orlistat umhlinzeki wakho angakumisela lona. Ungathenga futhi i-orlistat ngaphandle kwemithi kadokotela ngaphansi kwegama elithi Alli. La maphilisi ayingxenye yamandla weXenical. I-Orlistat ibiza cishe u- $ 100 noma ngaphezulu ngenyanga. Cabanga ukuthi ngabe izindleko, imiphumela engemihle, kanye nokwehla kwesisindo okuncane ongakulindela kukufanele yini kuwe.

Umzimba wakho kungenzeka ungamunci amavithamini abalulekile, amaminerali, nezinye izakhamzimba ekudleni ngenkathi usebenzisa i-orlistat. Kufanele uthathe i-multivitamin yansuku zonke uma usebenzisa i-orlistat.

IMITHI EPHATHELELA ISIFISO

Le mithi isebenza ebuchosheni bakho ngokwenza ungabi nentshisekelo ekudleni.

Akuwona wonke umuntu owehlisa isisindo ngenkathi ethatha imithi. Iningi labantu libuyisa isisindo ngemuva kokuyeka ukuthatha umuthi, ngaphandle kokuthi benze izinguquko zokuphila okuphakade. Khuluma nomhlinzeki wakho mayelana nokuthi ungalahlekelwa isisindo esingakanani ngokuthatha noma iyiphi yale mithi.

Le mithi itholakala kuphela ngemithi kadokotela. Kubandakanya:

• I-Phentermine (Adipex-P, Lomaira, Phentercot, Phentride, Pro-Fast)
• Phentermine kuhlangene topiramate (Qsymia)
• I-Benzphetamine, Phendimetrazine (Bontril, Obezine, Phendiet, Prelu-2)
• I-Diethylpropion (iTenuate)
• INaltrexone ihlanganiswe ne-bupropion (Contrave)
• I-Lorcaserin (Belviq)

I-lorcaserin ne-phentermine / topiramate kuphela evunyelwe ukusetshenziswa isikhathi eside. Zonke ezinye izidakamizwa zivunyelwe ukusetshenziswa kwesikhashana ezingekho ngaphezu kwamasonto ambalwa.

Qiniseka ukuthi uyayiqonda imiphumela emibi yemithi yokwehlisa isisindo. Imiphumela emibi ingafaka:

• Khulisa umfutho wegazi
• Izinkinga zokulala, ikhanda elibuhlungu, ukwethuka nokushaywa
• Isicanucanu, ukuqunjelwa, nomlomo owomile
• Ukudangala, abanye abantu abakhuluphele abalwa nakho

Uma unesifo sikashukela esidinga ukwelashwa ngemithi, ungahle uthande ukubuza umhlinzeki wakho ngemithi yesifo sikashukela edala ukwehla kwesisindo. Lokhu kufaka phakathi:

• I-Canagliflozin (i-Invokana)
• I-Dapagliflozin (Farxiga)
• IDapagliflozin ihlangene ne-saxagliptin (Qtern)
• I-Dulaglutide (Trulicity)
• I-Empagliflozin (Jardiance)
• I-Exenatide (Byetta, Bydureon)
• I-Liraglutide (Victoza)
• I-Lixisenatide (Adlyxin)
• IMetformin (iGlucophage, iGlumetza, neFortamet)
• I-Semaglutide (Ozempic)

Le mithi ayivunyelwe yi-FDA ukwelapha ukwehla kwesisindo. Ngakho-ke akufanele uwaphuze uma ungenaso isifo sikashukela.

Imithi kadokotela yokunciphisa umzimba; Isifo sikashukela - izidakamizwa zokunciphisa umzimba; Ukukhuluphala - izidakamizwa zokwehlisa isisindo; Ukhuluphele - izidakamizwa zokwehlisa isisindo

I-Apovian CM, u-Aronne LJ, uBessesen DH, et al .; I-Endocrine Society. Ukuphathwa kwemithi yokukhuluphala: umhlahlandlela wokusebenza komtholampilo we-endocrine Society. UJ Clin Endocrinol Metab. 2015; 100 (2): 342-362. I-PMID: 25590212 www.ncbi.nlm.nih.gov/pubmed/25590212.

UJensen MD. Ukukhuluphala ngokweqile. Ku: IGoldman L, iSchafer AI, ama-eds. Imithi yeGoldman-Cecil. Umhla ka-25. IPhiladelphia, PA: Elsevier Saunders; 2016: isahluko 220.

UKlein S, uRomijn JA. Ukukhuluphala ngokweqile. Ku: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, abahleli. Incwadi kaWilliams ye-Endocrinology. Umhlaka 13. IPhiladelphia, PA: Elsevier; 2016: isahluko 36.

UMordes JP, Liu C, Xu S. Imithi yokwehlisa isisindo. I-Curr Opin Endocrinol Isifo Sikashukela Obes. 2015; 22 (2): 91-97. I-PMID: 25692921 www.ncbi.nlm.nih.gov/pubmed/25692921.

• Ukulawula Isisindo